Kaival Brands Innovations Group Inc

We believe we will not have sufficient cash on hand to support our operations for at least 12 months. As of January 31, 2024, we had working capital of approximately $330,917 and total cash of approximately $591,293. As discussed above, this condition and other factors raise substantial doubt regarding our ability to continue as a going concern.

We intend to generally rely on cash from operations and equity and debt offerings to the extent necessary and available, to satisfy our liquidity needs. There are several factors that could result in the need to raise additional funds, including a decline in revenue, a lack of anticipated sales growth, increased costs and our potential plan to redeem for cash the shares of our Series B Preferred Stock issued in connection with our GoFire asset purchase in May 2023. Our efforts are directed toward generating positive cash flow and, ultimately, profitability. As our efforts during our fiscal 2023 and since have not generated positive cash flows, we will need to raise additional capital. Should capital not be available to us at reasonable terms, other actions will become necessary, including implementing cost control measures and additional efforts to increase sales. We may also be required to take more strategic actions such as exploring strategic options for the sale of our company, the creation of joint ventures or strategic alliances under which we will pursue business opportunities, or other alternatives. We believe we have, or have access to, the financial resources to weather the impacts of the FDA’s PMTA process and Bidi’s receipt of MDOs from the FDA in 2021 and 2024, which are subject to additional FDA action and ongoing court proceedings, respectively. However, we will require further financing for the next twelve months, given our operating results.

Cash Flows:

Net cash flows provided by operations was approximately $0.2 million for the first three months of fiscal year 2024, compared to $0.1 million cash flows provided by operations for the first three months of fiscal year 2023. The increase in cash flows provided by operations for the three months ended 2024 compared to the three months ended 2023 was primarily due to changes in inventory and accounts receivable.

Net cash flows used by financing activities was approximately $0.2 million for the three months of fiscal year 2024, compared to cash flows used in financing activities of approximately $0 for the three months of fiscal year 2023. The cash used by financing activities for the three months ended 2024 consisted primarily of proceeds offset by payments on Loans payables.